A new drug that showed promise in animal studies and an early clinical trial didn't improve disability among stroke patients, according to late-breaking research presented at the American Stroke Association's International Stroke Conference 2012. After a stroke and other types of brain damage, the brain naturally produces more granulocyte colony stimulating factor (G-CSF). The protein can prevent further cell injury by protecting nerve cells and boosting blood vessel growth. The new drug, AX200, is a manufactured form of G-CSF...
Realtime Related Tweets
Source: http://www.kiefit.com/Health_Fitness/disability-among-stroke-patients-not-improved-by-new-drug/
tony blankley steelers blue ivy carter pittsburgh steelers charles barkley beyonce hines ward
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.